Dermatologists create First-Ever rules for Anti-Aging acne drug
NCT ID NCT07296536
Summary
This study gathers expert dermatologists to create standardized guidelines for using low-dose isotretinoin to improve skin texture and combat signs of aging. Fifteen experienced dermatologists will participate in multiple rounds of surveys to reach agreement on safe dosing, patient selection, and monitoring protocols. The goal is to establish practical recommendations for using this acne medication in skin rejuvenation programs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISOTRETINOIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Venus Research Center
Cairo, Egypt
Conditions
Explore the condition pages connected to this study.